Piper Sandler raised the firm’s price target on Abacus Life (ABL) to $13 from $12 and keeps an Overweight rating on the shares following quarterly earnings. Given the strength through the first three quarters of the year and the outlook, the firm is increasing its adjusted EBITDA estimate, Piper told investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio